バイオプロセス容器市場(タイプ:2Dバイオプロセス容器、用途:3Dバイオプロセス容器、その他タイプ:2Dバイオプロセスコンテナー、3Dバイオプロセスコンテナー、その他;用途:上流プロセス、下流プロセス、プロセス開発) - 世界の産業分析、規模、シェア、成長、動向、予測、2023-2033年Bioprocess Containers Market (Type: 2D Bioprocess Containers, 3D Bioprocess Containers, and Others; Application: Upstream Processes, Downstream Processes, and Process Development) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2033 バイオプロセス容器市場 - レポートの範囲 TMRの調査レポート「世界のバイオプロセス容器市場」は、2023年から2033年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーバイオプロセス容器市場 - レポートの範囲TMRの調査レポート「世界のバイオプロセス容器市場」は、2023年から2033年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2033年を予測年として、2017年から2033年までの世界のバイオプロセス容器市場の収益を提供しています。また、2023年から2033年までの世界のバイオプロセス容器市場の複合年間成長率(CAGR %)も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照し、バイオプロセス容器市場を理解しました。 二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれる。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界のバイオプロセス容器市場の様々な属性を調査した。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界のバイオプロセス容器市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場関係者だけでなく、世界のバイオプロセス容器市場への参入に関心のある企業にとっても貴重なツールとなります。 本レポートでは、世界のバイオプロセス容器市場の競争環境について掘り下げています。世界のバイオプロセス容器市場で事業を展開する主要企業が特定され、その各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界のバイオプロセス容器市場のプレーヤーの属性である。 バイオプロセス容器の世界市場レポートが回答した主要な質問 - 予測期間中の全地域におけるバイオプロセス容器の売上高/収益は? - 世界のバイオプロセス容器市場におけるビジネスチャンスは? - 市場の主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大する地域市場はどこか? - 2033年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? - 世界市場で事業を展開する各企業の市場ポジションは? バイオプロセス容器市場 - 調査目的と調査アプローチ バイオプロセス容器の世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品承認のための規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかける。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。 本レポートでは、世界のバイオプロセス容器市場を製品、エンドユーザー、地域の観点から分析している。各基準における主要セグメントを詳細に調査し、2033年末時点の各セグメントにおける市場シェアを掲載している。このような貴重な洞察により、市場関係者は世界のバイオプロセス容器市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Bioprocess Containers Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Bioprocess Containers Market Analysis and Forecast, 2017-2033 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Technological Advancements 5.2. Key Industry Events 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact) 6. Global Bioprocess Containers Market Analysis and Forecast, by Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Type, 2017-2033 6.3.1. 2D Bioprocess Containers 6.3.2. 3D Bioprocess Containers 6.3.3. Others 6.4. Market Attractiveness Analysis, by Type 7. Global Bioprocess Containers Market Analysis and Forecast, by Capacity 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Capacity, 2017-2033 7.3.1. Small Volume 7.3.2. Large Volume 7.4. Market Attractiveness Analysis, by Capacity 8. Global Bioprocess Containers Market Analysis and Forecast, by Application 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by Application, 2017-2033 8.3.1. Upstream Processes 8.3.2. Downstream Processes 8.3.3. Process Development 8.4. Market Attractiveness Analysis, by Application 9. Global Bioprocess Containers Market Analysis and Forecast, by End-user 9.1. Introduction & Definition 9.2. Key Findings / Developments 9.3. Market Value Forecast, by End-user, 2017-2033 9.3.1. Pharmaceutical & Biotechnology Companies 9.3.2. CROs & CMOs 9.3.3. Academic & Research Institutes 9.4. Market Attractiveness Analysis, by End-user 10. Global Bioprocess Containers Market Analysis and Forecast, by Region 10.1. Key Findings 10.2. Market Value Forecast, by Region 10.2.1. North America 10.2.2. Europe 10.2.3. Asia Pacific 10.2.4. Latin America 10.2.5. Middle East & Africa 10.3. Market Attractiveness Analysis, by Region 11. North America Bioprocess Containers Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Type, 2017-2033 11.2.1. 2D Bioprocess Containers 11.2.2. 3D Bioprocess Containers 11.2.3. Others 11.3. Market Value Forecast, by Capacity, 2017-2033 11.3.1. Small Volume 11.3.2. Large Volume 11.4. Market Value Forecast, by Application, 2017-2033 11.4.1. Upstream Processes 11.4.2. Downstream Processes 11.4.3. Process Development 11.5. Market Value Forecast, by End-user, 2017-2033 11.5.1. Pharmaceutical & Biotechnology Companies 11.5.2. CROs & CMOs 11.5.3. Academic & Research Institutes 11.6. Market Value Forecast, by Country, 2017-2033 11.6.1. U.S. 11.6.2. Canada 11.7. Market Attractiveness Analysis 11.7.1. By Type 11.7.2. By Capacity 11.7.3. By Application 11.7.4. By End-user 11.7.5. By Country 12. Europe Bioprocess Containers Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Type, 2017-2033 12.2.1. 2D Bioprocess Containers 12.2.2. 3D Bioprocess Containers 12.2.3. Others 12.3. Market Value Forecast, by Capacity, 2017-2033 12.3.1. Small Volume 12.3.2. Large Volume 12.4. Market Value Forecast, by Application, 2017-2033 12.4.1. Upstream Processes 12.4.2. Downstream Processes 12.4.3. Process Development 12.5. Market Value Forecast, by End-user, 2017-2033 12.5.1. Pharmaceutical & Biotechnology Companies 12.5.2. CROs & CMOs 12.5.3. Academic & Research Institutes 12.6. Market Value Forecast, by Country/Sub-region, 2017-2033 12.6.1. Germany 12.6.2. U.K. 12.6.3. France 12.6.4. Italy 12.6.5. Spain 12.6.6. Rest of Europe 12.7. Market Attractiveness Analysis 12.7.1. By Type 12.7.2. By Capacity 12.7.3. By Application 12.7.4. By End-user 12.7.5. By Country/Sub-region 13. Asia Pacific Bioprocess Containers Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Type, 2017-2033 13.2.1. 2D Bioprocess Containers 13.2.2. 3D Bioprocess Containers 13.2.3. Others 13.3. Market Value Forecast, by Capacity, 2017-2033 13.3.1. Small Volume 13.3.2. Large Volume 13.4. Market Value Forecast, by Application, 2017-2033 13.4.1. Upstream Processes 13.4.2. Downstream Processes 13.4.3. Process Development 13.5. Market Value Forecast, by End-user, 2017-2033 13.5.1. Pharmaceutical & Biotechnology Companies 13.5.2. CROs & CMOs 13.5.3. Academic & Research Institutes 13.6. Market Value Forecast, by Country/Sub-region, 2017-2033 13.6.1. China 13.6.2. Japan 13.6.3. India 13.6.4. Australia & New Zealand 13.6.5. Rest of Asia Pacific 13.7. Market Attractiveness Analysis 13.7.1. By Type 13.7.2. By Capacity 13.7.3. By Application 13.7.4. By End-user 13.7.5. By Country/Sub-region 14. Latin America Bioprocess Containers Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Type, 2017-2033 14.2.1. 2D Bioprocess Containers 14.2.2. 3D Bioprocess Containers 14.2.3. Others 14.3. Market Value Forecast, by Capacity, 2017-2033 14.3.1. Small Volume 14.3.2. Large Volume 14.4. Market Value Forecast, by Application, 2017-2033 14.4.1. Upstream Processes 14.4.2. Downstream Processes 14.4.3. Process Development 14.5. Market Value Forecast, by End-user, 2017-2033 14.5.1. Pharmaceutical & Biotechnology Companies 14.5.2. CROs & CMOs 14.5.3. Academic & Research Institutes 14.6. Market Value Forecast, by Country/Sub-region, 2017-2033 14.6.1. Brazil 14.6.2. Mexico 14.6.3. Rest of Latin America 14.7. Market Attractiveness Analysis 14.7.1. By Type 14.7.2. By Capacity 14.7.3. By Application 14.7.4. By End-user 14.7.5. By Country/Sub-region 15. Middle East & Africa Bioprocess Containers Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast, by Type, 2017-2033 15.2.1. 2D Bioprocess Containers 15.2.2. 3D Bioprocess Containers 15.2.3. Others 15.3. Market Value Forecast, by Capacity, 2017-2033 15.3.1. Small Volume 15.3.2. Large Volume 15.4. Market Value Forecast, by Application, 2017-2033 15.4.1. Upstream Processes 15.4.2. Downstream Processes 15.4.3. Process Development 15.5. Market Value Forecast, by End-user, 2017-2033 15.5.1. Pharmaceutical & Biotechnology Companies 15.5.2. CROs & CMOs 15.5.3. Academic & Research Institutes 15.6. Market Value Forecast, by Country/Sub-region, 2017-2033 15.6.1. GCC Countries 15.6.2. South Africa 15.6.3. Rest of Middle East & Africa 15.7. Market Attractiveness Analysis 15.7.1. By Type 15.7.2. By Capacity 15.7.3. By Application 15.7.4. By End-user 15.7.5. By Country/Sub-region 16. Competition Landscape 16.1. Market Player - Competition Matrix (By Tier and Size of companies) 16.2. Market Share Analysis By Company (2022) 16.3. Company Profiles 16.3.1. Sartorius AG 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.1.2. Product Portfolio 16.3.1.3. Financial Overview 16.3.1.4. SWOT Analysis 16.3.1.5. Strategic Overview 16.3.2. Thermo Fisher Scientific Inc. 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2.2. Product Portfolio 16.3.2.3. Financial Overview 16.3.2.4. SWOT Analysis 16.3.2.5. Strategic Overview 16.3.3. Danaher Corporation 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.3.2. Product Portfolio 16.3.3.3. Financial Overview 16.3.3.4. SWOT Analysis 16.3.3.5. Strategic Overview 16.3.4. Merck KGaA 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.4.2. Product Portfolio 16.3.4.3. Financial Overview 16.3.4.4. SWOT Analysis 16.3.4.5. Strategic Overview 16.3.5. Corning Incorporated 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.5.2. Product Portfolio 16.3.5.3. Financial Overview 16.3.5.4. SWOT Analysis 16.3.5.5. Strategic Overview 16.3.6. Saint-Gobain 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.6.2. Product Portfolio 16.3.6.3. Financial Overview 16.3.6.4. SWOT Analysis 16.3.6.5. Strategic Overview 16.3.7. Avantor, Inc. 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.7.2. Product Portfolio 16.3.7.3. Financial Overview 16.3.7.4. SWOT Analysis 16.3.7.5. Strategic Overview 16.3.8. Parker Hannifin Corporation 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.8.2. Product Portfolio 16.3.8.3. Financial Overview 16.3.8.4. SWOT Analysis 16.3.8.5. Strategic Overview 16.3.9. Entegris, Inc. 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.9.2. Product Portfolio 16.3.9.3. Financial Overview 16.3.9.4. SWOT Analysis 16.3.9.5. Strategic Overview 16.3.10. Meissner Filtration Products, Inc. 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.10.2. Product Portfolio 16.3.10.3. Financial Overview 16.3.10.4. SWOT Analysis 16.3.10.5. Strategic Overview 16.3.11. Lonza AG 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.11.2. Product Portfolio 16.3.11.3. Financial Overview 16.3.11.4. SWOT Analysis 16.3.11.5. Strategic Overview 16.3.12. Flexbiosys Inc. 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.12.2. Product Portfolio 16.3.12.3. Financial Overview 16.3.12.4. SWOT Analysis 16.3.12.5. Strategic Overview 16.3.13. ABEC, Inc. 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.13.2. Product Portfolio 16.3.13.3. Financial Overview 16.3.13.4. SWOT Analysis 16.3.13.5. Strategic Overview 16.3.14. Cellexus 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.14.2. Product Portfolio 16.3.14.3. Financial Overview 16.3.14.4. SWOT Analysis 16.3.14.5. Strategic Overview
SummaryBioprocess Containers Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Bioprocess Containers Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Bioprocess Containers Market Analysis and Forecast, 2017-2033 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Technological Advancements 5.2. Key Industry Events 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact) 6. Global Bioprocess Containers Market Analysis and Forecast, by Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Type, 2017-2033 6.3.1. 2D Bioprocess Containers 6.3.2. 3D Bioprocess Containers 6.3.3. Others 6.4. Market Attractiveness Analysis, by Type 7. Global Bioprocess Containers Market Analysis and Forecast, by Capacity 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Capacity, 2017-2033 7.3.1. Small Volume 7.3.2. Large Volume 7.4. Market Attractiveness Analysis, by Capacity 8. Global Bioprocess Containers Market Analysis and Forecast, by Application 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by Application, 2017-2033 8.3.1. Upstream Processes 8.3.2. Downstream Processes 8.3.3. Process Development 8.4. Market Attractiveness Analysis, by Application 9. Global Bioprocess Containers Market Analysis and Forecast, by End-user 9.1. Introduction & Definition 9.2. Key Findings / Developments 9.3. Market Value Forecast, by End-user, 2017-2033 9.3.1. Pharmaceutical & Biotechnology Companies 9.3.2. CROs & CMOs 9.3.3. Academic & Research Institutes 9.4. Market Attractiveness Analysis, by End-user 10. Global Bioprocess Containers Market Analysis and Forecast, by Region 10.1. Key Findings 10.2. Market Value Forecast, by Region 10.2.1. North America 10.2.2. Europe 10.2.3. Asia Pacific 10.2.4. Latin America 10.2.5. Middle East & Africa 10.3. Market Attractiveness Analysis, by Region 11. North America Bioprocess Containers Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Type, 2017-2033 11.2.1. 2D Bioprocess Containers 11.2.2. 3D Bioprocess Containers 11.2.3. Others 11.3. Market Value Forecast, by Capacity, 2017-2033 11.3.1. Small Volume 11.3.2. Large Volume 11.4. Market Value Forecast, by Application, 2017-2033 11.4.1. Upstream Processes 11.4.2. Downstream Processes 11.4.3. Process Development 11.5. Market Value Forecast, by End-user, 2017-2033 11.5.1. Pharmaceutical & Biotechnology Companies 11.5.2. CROs & CMOs 11.5.3. Academic & Research Institutes 11.6. Market Value Forecast, by Country, 2017-2033 11.6.1. U.S. 11.6.2. Canada 11.7. Market Attractiveness Analysis 11.7.1. By Type 11.7.2. By Capacity 11.7.3. By Application 11.7.4. By End-user 11.7.5. By Country 12. Europe Bioprocess Containers Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Type, 2017-2033 12.2.1. 2D Bioprocess Containers 12.2.2. 3D Bioprocess Containers 12.2.3. Others 12.3. Market Value Forecast, by Capacity, 2017-2033 12.3.1. Small Volume 12.3.2. Large Volume 12.4. Market Value Forecast, by Application, 2017-2033 12.4.1. Upstream Processes 12.4.2. Downstream Processes 12.4.3. Process Development 12.5. Market Value Forecast, by End-user, 2017-2033 12.5.1. Pharmaceutical & Biotechnology Companies 12.5.2. CROs & CMOs 12.5.3. Academic & Research Institutes 12.6. Market Value Forecast, by Country/Sub-region, 2017-2033 12.6.1. Germany 12.6.2. U.K. 12.6.3. France 12.6.4. Italy 12.6.5. Spain 12.6.6. Rest of Europe 12.7. Market Attractiveness Analysis 12.7.1. By Type 12.7.2. By Capacity 12.7.3. By Application 12.7.4. By End-user 12.7.5. By Country/Sub-region 13. Asia Pacific Bioprocess Containers Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Type, 2017-2033 13.2.1. 2D Bioprocess Containers 13.2.2. 3D Bioprocess Containers 13.2.3. Others 13.3. Market Value Forecast, by Capacity, 2017-2033 13.3.1. Small Volume 13.3.2. Large Volume 13.4. Market Value Forecast, by Application, 2017-2033 13.4.1. Upstream Processes 13.4.2. Downstream Processes 13.4.3. Process Development 13.5. Market Value Forecast, by End-user, 2017-2033 13.5.1. Pharmaceutical & Biotechnology Companies 13.5.2. CROs & CMOs 13.5.3. Academic & Research Institutes 13.6. Market Value Forecast, by Country/Sub-region, 2017-2033 13.6.1. China 13.6.2. Japan 13.6.3. India 13.6.4. Australia & New Zealand 13.6.5. Rest of Asia Pacific 13.7. Market Attractiveness Analysis 13.7.1. By Type 13.7.2. By Capacity 13.7.3. By Application 13.7.4. By End-user 13.7.5. By Country/Sub-region 14. Latin America Bioprocess Containers Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Type, 2017-2033 14.2.1. 2D Bioprocess Containers 14.2.2. 3D Bioprocess Containers 14.2.3. Others 14.3. Market Value Forecast, by Capacity, 2017-2033 14.3.1. Small Volume 14.3.2. Large Volume 14.4. Market Value Forecast, by Application, 2017-2033 14.4.1. Upstream Processes 14.4.2. Downstream Processes 14.4.3. Process Development 14.5. Market Value Forecast, by End-user, 2017-2033 14.5.1. Pharmaceutical & Biotechnology Companies 14.5.2. CROs & CMOs 14.5.3. Academic & Research Institutes 14.6. Market Value Forecast, by Country/Sub-region, 2017-2033 14.6.1. Brazil 14.6.2. Mexico 14.6.3. Rest of Latin America 14.7. Market Attractiveness Analysis 14.7.1. By Type 14.7.2. By Capacity 14.7.3. By Application 14.7.4. By End-user 14.7.5. By Country/Sub-region 15. Middle East & Africa Bioprocess Containers Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast, by Type, 2017-2033 15.2.1. 2D Bioprocess Containers 15.2.2. 3D Bioprocess Containers 15.2.3. Others 15.3. Market Value Forecast, by Capacity, 2017-2033 15.3.1. Small Volume 15.3.2. Large Volume 15.4. Market Value Forecast, by Application, 2017-2033 15.4.1. Upstream Processes 15.4.2. Downstream Processes 15.4.3. Process Development 15.5. Market Value Forecast, by End-user, 2017-2033 15.5.1. Pharmaceutical & Biotechnology Companies 15.5.2. CROs & CMOs 15.5.3. Academic & Research Institutes 15.6. Market Value Forecast, by Country/Sub-region, 2017-2033 15.6.1. GCC Countries 15.6.2. South Africa 15.6.3. Rest of Middle East & Africa 15.7. Market Attractiveness Analysis 15.7.1. By Type 15.7.2. By Capacity 15.7.3. By Application 15.7.4. By End-user 15.7.5. By Country/Sub-region 16. Competition Landscape 16.1. Market Player - Competition Matrix (By Tier and Size of companies) 16.2. Market Share Analysis By Company (2022) 16.3. Company Profiles 16.3.1. Sartorius AG 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.1.2. Product Portfolio 16.3.1.3. Financial Overview 16.3.1.4. SWOT Analysis 16.3.1.5. Strategic Overview 16.3.2. Thermo Fisher Scientific Inc. 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2.2. Product Portfolio 16.3.2.3. Financial Overview 16.3.2.4. SWOT Analysis 16.3.2.5. Strategic Overview 16.3.3. Danaher Corporation 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.3.2. Product Portfolio 16.3.3.3. Financial Overview 16.3.3.4. SWOT Analysis 16.3.3.5. Strategic Overview 16.3.4. Merck KGaA 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.4.2. Product Portfolio 16.3.4.3. Financial Overview 16.3.4.4. SWOT Analysis 16.3.4.5. Strategic Overview 16.3.5. Corning Incorporated 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.5.2. Product Portfolio 16.3.5.3. Financial Overview 16.3.5.4. SWOT Analysis 16.3.5.5. Strategic Overview 16.3.6. Saint-Gobain 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.6.2. Product Portfolio 16.3.6.3. Financial Overview 16.3.6.4. SWOT Analysis 16.3.6.5. Strategic Overview 16.3.7. Avantor, Inc. 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.7.2. Product Portfolio 16.3.7.3. Financial Overview 16.3.7.4. SWOT Analysis 16.3.7.5. Strategic Overview 16.3.8. Parker Hannifin Corporation 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.8.2. Product Portfolio 16.3.8.3. Financial Overview 16.3.8.4. SWOT Analysis 16.3.8.5. Strategic Overview 16.3.9. Entegris, Inc. 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.9.2. Product Portfolio 16.3.9.3. Financial Overview 16.3.9.4. SWOT Analysis 16.3.9.5. Strategic Overview 16.3.10. Meissner Filtration Products, Inc. 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.10.2. Product Portfolio 16.3.10.3. Financial Overview 16.3.10.4. SWOT Analysis 16.3.10.5. Strategic Overview 16.3.11. Lonza AG 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.11.2. Product Portfolio 16.3.11.3. Financial Overview 16.3.11.4. SWOT Analysis 16.3.11.5. Strategic Overview 16.3.12. Flexbiosys Inc. 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.12.2. Product Portfolio 16.3.12.3. Financial Overview 16.3.12.4. SWOT Analysis 16.3.12.5. Strategic Overview 16.3.13. ABEC, Inc. 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.13.2. Product Portfolio 16.3.13.3. Financial Overview 16.3.13.4. SWOT Analysis 16.3.13.5. Strategic Overview 16.3.14. Cellexus 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.14.2. Product Portfolio 16.3.14.3. Financial Overview 16.3.14.4. SWOT Analysis 16.3.14.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Transparency Market Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD(industry)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |